Why do so many expensive therapies and “specialized” programs seem to cluster around Ehlers-Danlos Syndrome (EDS)? And how can patients tell when something is truly helpful… versus when it’s simply well marketed?
On today’s episode of @bendy_bodies, I spoke with neuro opthamologist Dr. Eric L. Singman about how to think critically about treatments, products, and providers that claim to be EDS-specific. One red flag worth noticing: when the same person recommending a therapy is also the one financially benefiting from it and/or if they say they are the ONLY one that can provide the treatment.
A powerful question to ask is this: What happens if I don’t do this treatment? Will my health actually worsen—or is urgency being implied without clear evidence? Not every intervention is time-sensitive, and not every high-price offering is essential.
Dr. Singman also pointed to one of the greatest strengths of the EDS community: people talk. They compare experiences, share outcomes, and openly discuss what helped, what didn’t, and what wasn’t worth the cost. That collective wisdom can be a powerful tool for making more informed, confident decisions.
💬 Curious to hear from you: Have you ever paused before a treatment and wondered whether it was truly necessary—or just very convincingly presented?
#BendyBodies #EhlersDanlosSyndrome #HypermobilitySpectrumDisorder #PatientAdvocacy #ChronicIllnessAwareness
📌 Medical Advice Disclaimer: This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for personalized care.
VD: Dr. Eric L. Singman discussing EDS, wellness treatments, and how patients can evaluate care more critically on the Bendy Bodies Podcast.
